Lab Automation Market By Product Type (Automated Workstations, Robotics, Laboratory Information Systems), By Application (Drug Discovery, Clinical Diagnostics, Genomics and Proteomics, Microbiology), By End-User (Pharmaceutical & Biotechnology Companies, Hospitals and Diagnostic Labs, Research and Academic Institutes), and By Region; Global Insights & Forecast (2023 – 2030)

As per Intent Market Research, the Lab Automation Market was valued at USD 8.1 billion in 2024-e and will surpass USD 14.0 billion by 2030; growing at a CAGR of 9.4% during 2025 - 2030.

The lab automation market is experiencing rapid growth, driven by the increasing need for high-throughput testing, improved accuracy, and reduced operational costs in laboratories across various industries. Automation technologies, such as robotic systems, automated workstations, and laboratory information systems (LIS), are transforming laboratories by streamlining complex processes, enhancing productivity, and minimizing human error. The market is particularly influenced by advancements in biotechnology, pharmaceutical research, and clinical diagnostics, which require efficient and reliable testing methods.

The rising demand for personalized medicine, genomics research, and drug development is further propelling the adoption of lab automation systems. These systems not only accelerate research timelines but also improve data management, enabling laboratories to process larger volumes of samples with increased efficiency. As automation technologies continue to evolve, their integration with artificial intelligence and machine learning is expected to open new frontiers in lab processes, offering greater precision and automation capabilities.

Automated Workstations Segment is Largest Owing to Versatility and Increased Demand

The automated workstations segment holds the largest share of the lab automation market, owing to their versatility and widespread adoption in laboratory settings. Automated workstations can handle various laboratory tasks such as sample preparation, liquid handling, and analysis, offering a significant reduction in labor costs while improving throughput and accuracy.

Their ability to integrate with different laboratory instruments and software systems makes automated workstations indispensable in diverse applications, ranging from clinical diagnostics to drug discovery. The growing focus on high-throughput screening in pharmaceutical and biotechnology industries is driving the demand for these systems, ensuring their continued dominance in the market.

Clinical Diagnostics Application Segment is Largest Owing to High Throughput Testing Needs

The clinical diagnostics application segment is the largest within the lab automation market, largely due to the increasing demand for high-throughput diagnostic testing in hospitals, diagnostic labs, and research institutes. Lab automation systems in this segment help streamline the testing process, providing faster results and reducing the likelihood of human error.

With the rise in chronic diseases, infectious diseases, and the need for personalized diagnostics, clinical diagnostics has become a focal point for lab automation companies. The integration of automation in diagnostic workflows enables laboratories to handle large sample volumes, optimize testing accuracy, and enhance turnaround time, all of which are essential in today’s healthcare environment.

Pharmaceutical & Biotechnology Companies End-User Segment is Largest Owing to Research and Development Focus

Pharmaceutical and biotechnology companies dominate the lab automation market as the largest end-user segment, driven by their extensive research and development (R&D) efforts. These companies rely on lab automation systems to accelerate drug discovery, preclinical testing, and clinical trials, ensuring high throughput and reproducibility in their experiments.

Automation plays a key role in reducing the time and cost associated with R&D processes. It also supports the development of personalized medicines and biopharmaceuticals, allowing for precise experimentation and data collection. The continuous evolution of biologics and gene therapies further fuels the demand for advanced lab automation solutions in these industries.

North America is Largest Region Owing to Strong Infrastructure and Research Capabilities

North America is the largest region in the lab automation market, primarily due to its advanced healthcare infrastructure, leading pharmaceutical and biotechnology companies, and strong research capabilities. The United States, in particular, is at the forefront of adopting lab automation technologies, driven by a robust healthcare system and increasing investments in biotech and pharmaceutical sectors.

In addition, the presence of major research institutions and hospitals contributes to the growing demand for automation solutions that can improve workflow efficiencies and support the rising need for high-throughput testing. The region's favorable regulatory environment and continuous innovation further cement its leadership in the global lab automation market.

Competitive Landscape

The lab automation market is highly competitive, with key players such as Thermo Fisher Scientific, Agilent Technologies, Siemens Healthineers, and Beckman Coulter leading the industry. These companies dominate the market through a combination of product innovation, strategic partnerships, and a strong presence in key applications such as drug discovery and clinical diagnostics.

Emerging players are also contributing to market growth, particularly in areas such as genomics and microbiology, where automation is increasingly being adopted for high-volume sample processing. As demand for lab automation solutions continues to rise, the competitive landscape is expected to become more dynamic, with companies focusing on developing next-generation automation technologies that integrate artificial intelligence and data analytics to enhance laboratory efficiency and accuracy.

Recent Developments:

• In December 2024, Thermo Fisher Scientific launched a fully automated liquid handling workstation.
• In November 2024, Agilent Technologies introduced a new robotic system for high-throughput screening.
• In October 2024, Danaher acquired a startup specializing in AI-powered lab automation software.
• In September 2024, Hamilton Company unveiled an advanced microplate reader with integrated robotics.
• In August 2024, PerkinElmer expanded its laboratory automation portfolio with a new genomics analysis platform.

List of Leading Companies:

• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• Danaher Corporation
• PerkinElmer, Inc.
• Tecan Group Ltd.
• Hamilton Company
• Eppendorf AG
• Siemens Healthineers
• Bio-Rad Laboratories, Inc.
• Roche Diagnostics
• Beckman Coulter, Inc. (Danaher)
• Brooks Automation
• Synchron Lab Automation
• Hudson Robotics
• QIAGEN

Report Scope: